More
    Guided Solutions - Connecting Talent With Innovation/div>

    Nectero Medical closes $96M Series D

    Nectero Medical announced it closed a Series D financing round worth proceeds of $96 million. Norwest Venture Partners led the round. Boston Scientific, BioStar...

    Prothea debuts with $13m to develop cancer diagnostics and treatment

    The University of Edinburgh and Bath spin-off, Prothea Technologies, has closed €12m ($13m) in Series A financing to develop cancer diagnostics and therapeutics. The company...

    Biolinq raises $58m for glucose microsensor pivotal trial

    Biolinq has raised $58m in a financing round to support an ongoing pivotal trial investigating its wearable, non-invasive glucose sensor patch. Biolinq’s CEO Richard Yang...

    Neurava raises $2.3 Million for epilepsy monitoring technology

    Neurava announced today that it completed an oversubscribed seed financing round worth proceeds of $2.26 million. Indianapolis-based Neurava develops a novel wearable device for mitigating...

    EarliTec Diagnostics, Inc. Raises $21.5M in Series B Financing

    EarliTec Diagnostics, Inc. (“EarliTec”), a medical device company focused on diagnostic and therapeutic solutions for children with autism and related early childhood vulnerabilities, announced...

    ViaLase closes $40M series C financing to advance first femtosecond laser for Glaucoma treatment

    ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it has closed...

    Diagnostics startup Noze awarded $1.8m grant for World Tuberculosis Day

    Canadian diagnostic startup, Noze, has been awarded $1.8m to launch a clinical study aimed at detecting tuberculosis (TB) in high-burden countries using the company’s...

    Metyos raises €2.3 million to boost wearable kidney disease device

    French startup Metyos has raised €2.3m ($2.49m) in seed funding for the company’s wearable sensor device, which is designed to monitor the condition of...

    Protembis Announces Completion of €30 Million Series B Financing Round

    Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a € 30 million Series B financing round to...

    Latest articles